Watch this short video to find out how we provide our clients with fresh and innovative solutions.
Simulations Plus announced today the partnership will develop machine learning models and approaches for potential treatments of pulmonary infections.
Join us and learn how QSP modeling can inform and accelerate drug development of anti-fibrotic medications and more!
Cognigen division has awarded a grant to the Department of Pharmacology and Therapeutics to fund upgraded internet capabilities, ensuring access to Cognigen’s KIWITM platform
MonolixSuite’s latest release (2020) introduces a new application for clinical trial simulations, with a user-friendly interface and interactive plots.
To improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services.
Providing strategic pharmacology and pharmacometric consulting services, PK/PD model development with NONMEM, clinical trial simulations, exposure-response evaluations, dose justification strategies and related data management services.
Ensuring the safety of drug therapies by leveraging our expertise in the areas of drug-induced liver injury, metabolic diseases, and modeling and simulation.
Lixoft products are designed to save the time and energy of pharmacometricians and biostatisticianby bringing breakthrough advances to the modeling & simulation community in user-friendly tools.
Stay up-to-date with our upcoming conference attendance & presentations, application webinars, and training workshop courses.
Find out how your peers are applying our technology by reviewing journal articles describing various user case studies.